Status:
RECRUITING
The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Lead Sponsor:
Radboud University Medical Center
Conditions:
Cancer
Oncology
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-saving...
Eligibility Criteria
Inclusion
- Patients of all ages
- A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC).
Exclusion
- Patients that do not understand the Dutch or English language, in written or spoken.
- Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package
Key Trial Info
Start Date :
January 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06566560
Start Date
January 10 2024
End Date
December 31 2024
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 GA